Product Information
HYSINGLA ER 80 MG TABLET is a brand product labeled by Purdue Pharma LP, priced at $48.6550 per EA under NDC 59011027560. Its NADAC has been published 528 times since May 18, 2016.
Strength
80 mg/1
Manufacturer
Purdue Pharma LPNDC
59011027560
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
HYDROCODONE BITARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA206627On Market Since
1/15/2015
Pharmacological Classes
Price Statistics
The NADAC for HYSINGLA ER 80 MG TABLET has been published 528 times since May 18, 2016, and over the history we have for it it has risen 92.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $48.6550 per EA |
|---|---|
| All-time high | $48.6550 (Jun 24, 2026) |
| All-time low | $24.6252 (Dec 21, 2016) |
| 52-week high | $48.6550 |
| 52-week low | $44.8433 |
| Median price | $36.7051 |
| Average price | $36.4213 |
| Largest weekly change | +9.5% (Jan 9, 2019) |
| Weeks tracked | 528 |
| Tracking since | May 18, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the hydrocodone bitartrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of HYSINGLA ER 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYSINGLA ER 80 MG TABLET, manufactured by Purdue Pharma LP, is $48.6550 per EA (NDC 59011027560), effective Jun 24, 2026.
How has the price of HYSINGLA ER 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYSINGLA ER 80 MG TABLET has risen 92.0%. It has been tracked across 528 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for HYSINGLA ER 80 MG TABLET?
Since May 18, 2016, the NADAC for HYSINGLA ER 80 MG TABLET has ranged from a low of $24.6252 (Dec 21, 2016) to a high of $48.6550 (Jun 24, 2026), with a median of $36.7051 per EA.
Are there cheaper alternatives to HYSINGLA ER 80 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HYSINGLA ER 80 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures HYSINGLA ER 80 MG TABLET?
HYSINGLA ER 80 MG TABLET (NDC 59011027560) is labeled by Purdue Pharma LP, and CMS classifies it as a brand product.
Related Drugs
Same classification